Pharmaceutical: The Last Six Months
Of Federal Activity

About

This Report

This is a computer-generated report that shows all of the federal activity with respect to the keyword "Pharmaceutical" over the last six months. This is a demonstration of the power of our government relations automation software.

Hansard

House: 10 Speeches
Senate: 5 Speeches

House Senate

Bills

Active: 0

Regulations

Filed: 0
Proposed: 0

The House

Mr. Don Davies (Vancouver Kingsway, NDP)

May 31st
Hansard Link

Government Orders

“... excise tax on medical cannabis. Currently, the situation in Canada is that we do not tax medicine. Pharmaceuticals go through a process and get something called a “drug identification number”, or DIN...”

Mr. Mark Gerretsen (Kingston and the Islands, Lib.)

May 31st
Hansard Link

Government Orders

“...dget, in particular the cannabis excise framework, specifically says that to help those who rely on pharmaceutical cannabis products to relieve pain or treat illness, the government will exempt these products from the excise duties, so long as they are acquired through a prescription. It goes on to say, similarly, “pharmaceutical products derived from cannabis will also be exempt, provided that the cannabis produc...”

Hon. Ginette Petitpas Taylor (Minister of Health, Lib.)

May 10th
Hansard Link

Oral Questions

“...ess the crisis. Unfortunately, at the same time when the United States was pursuing charges against pharmaceutical companies that inappropriately marketed opioids, the former Harper government failed ...”

Ms. Sheri Benson (Saskatoon West, NDP)

April 23rd
Hansard Link

Government Orders

“...The only people benefiting from yet again more talk, more consultation, and no action are the pharmaceutical companies, which continue to gouge Canadians and the health care system. Canadians pa...”

Mr. Kevin Lamoureux (Parliamentary Secretary to the Leader of the Government in the House of Commons, Lib.)

March 20th
Hansard Link

The Budget

“...y. It chose not to do that.

The Standing Committee on Health has recognized the importance of pharmaceuticals and the cost of medications. Its report has been brought forward. I think it is a st...”

Mr. Gabriel Ste-Marie

March 20th
Hansard Link

The Budget

“...lumbia's. We need more support for the high-tech, aerospace, and informatics industries. We saw our pharmaceutical sector collapse for lack of support. That is also the case for the manufacturing sect...”

Mr. Francis Scarpaleggia (Lac-Saint-Louis, Lib.)

March 19th
Hansard Link

The Budget

“...peutic approaches, and to the creation of local biotechnology enterprises or to collaborations with pharmaceutical companies internationally. [English]

By investing in fundamental science, ...”

Hon. Bill Morneau

February 27th
Hansard Link

The Budget

“... the government recognizes, that we need to consider how we can ensure all Canadians have access to pharmaceuticals. This is an important issue we need to deal with. The reason we are moving forward w...”

Hon. Bill Morneau

February 27th
Hansard Link

The Budget

“...ard pharmacare, what we are going to do is very carefully analyze how we can best deliver access to pharmaceuticals for all Canadians. We know that our system right now presents some Canadians with a ...”

Mr. Kevin Lamoureux (Winnipeg North, Lib.)

February 26th
Hansard Link

Routine Proceedings

“... pharmacare program, adding their voices to many others in terms of the need to look at the cost of pharmaceuticals that so many constituents are unable to afford. They are asking the government to lo...”


The Senate

Senator Ringuette

June 19th
Hansard Link

Cannabis Bill Motion in Amendment Negatived

“...o acquire medical marijuana with a prescription. Quite honestly, I wondered just how much of a hand pharmaceutical companies had in that. I read the excellent presentation that former minister Benoît ...”

Senator Seidman

June 1st
Hansard Link

Cannabis Bill Motion in Amendment Adopted

“...passed in 2014, still is not in full force protecting Canadians from the unintended consequences of pharmaceutical products —because the regulations are not written. There you go: 2014, legislation pa...”

Hon. Lillian Eva Dyck

May 22nd
Hansard Link

Food and Drugs Act Bill to Amend—Third Reading—Debate Continued

“...e, with this bill a new preservative which has been proved safe by animal testing could be used for pharmaceuticals but could not be used as an ingredient in a cosmetic. On those rare occasions, the m...”

Hon. Carolyn Stewart Olsen

March 1st
Hansard Link

Food and Drugs Act Bill to Amend—Third Reading—Debate Adjourned

“...od and Drugs Act has an unwieldy regulatory structure, which frustrates the cosmetics industry, the pharmaceutical industry, the consumer health products industry and many other stakeholders that I’ve heard of over the years, both in relation to Bill S-214 and regarding Health Canada in general. Counsel for Cosmetics Alliance Canada noted their difficulty in distinguishing the regulation of cosmetics, which one would use, and the chemical preservatives that are added to make those products shelf-stable. As I have stated in media interviews, Bill S-214 has a mechanism within it that empowers the Minister of Health to exempt products or their constituent ingredients if required. I am sure that, once the bill is passed, the ministry will be able to work with stakeholders over the four-year phase-in to ensure our industry is not penalized. The issue of preservatives is complicated and reaches beyond the cosmetics industry into pharmaceuticals and foods. That will be the case for years to come, regardless of this legislation. ...”

Hon. Lucie Moncion

February 27th
Hansard Link

Cannabis Bill Bill to Amend—Second Reading—Debate Continued

“...cts could even be placed in sealed, difficult to open containers, as is currently the case for some pharmaceuticals and highly toxic products or poisons. [Translation] Packaging for such products must...”


Was This Useful? Try Our Real-Time Alerts Product: Free Trial

Operated by Global-Regulation Inc.